Clinical Papers

Limitations of the US Food and Drug Administration laparoscopic banding trial All Clinical Papers
 
Martin et al [1] report on findings from a US Food and Drug Administration (FDA)-supervised trial of Inamed’s laparoscopic banding system. The data being reported are important since they provide valuable information collected in an externally monitored clinical trial, a rarity in the bariatric surgery literature. None of the plethora of studies reporting favorable results with banding procedures had this level of monitoring and these data should serve as a reference for laparoscopic banding outcomes. However, there are some important caveats.

Download
Privacy Policy | About Us | Contact Us | Sitemap | Risk Information
© 2010 Allergan, Inc., Irvine CA 92612, U.S.A. ® and TM Mark Owned by Allergan, Inc. All rights reserved. Lindora is a registered trademark owned by Lindora, Inc. COVIDIEN, COVIDIEN with logo and Covidien logo are U.S. and/or internationally registered trademarks of Covidien AG. FITDAY is a registered service mark of Internet Brands, Inc. CareCredit is a registered trademark of CareCredit LLC, General Electric Co, or their subsidiaries. Emmi is a registered trademark owned by Emmi Solutions, LLC. Realize™ is a trademark of Ethicon Endo-Surgery. YouTube is trademark owned by YouTube, LLC.  APC74CS10.
This site is intended for US residents only.